Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Upton

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
Allergy|December 10, 2020
Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy: The Markers of Nut Allergy StudyLucy Duan, Alper Celik, Jennifer A Hoang, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis TreatmentEric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
Aerobiologia|April 20, 2026
Five years of national airborne pollen monitoring in South Africa: biome-specific calendars to inform allergy diagnosis and preventionTakudzwa Matuvhunye, Dilys M Berman, Nanike Esterhuizen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 18, 2026
Age-Appropriate Low Dosing for FPIES Oral Food Challenges: Proposing a Standardized ApproachSara Anvari, Mary Grace Baker, Theresa Bingemann, et al.
Nature Communications|October 22, 2025
The role of cytochrome bc<sub>1</sub> inhibitors in future tuberculosis treatment regimensClara Aguilar-Pérez, Anne J Lenaerts, Cristina Villellas, et al.
The Lancet. Infectious Diseases|August 21, 2025
A clinical practice guideline for tuberculous meningitisJoseph Donovan, Fiona V Cresswell, Elizabeth W Tucker, et al.
Nature Medicine|July 6, 2021
The Tuberculosis Drug Accelerator at year 10: what have we learned?Bree B Aldridge, David Barros-Aguirre, Clifton E Barry, et al.
The Journal of Experimental Medicine|November 11, 2024
Human ITGAV variants are associated with immune dysregulation, brain abnormalities, and colitisSina Ghasempour, Neil Warner, Rei Guan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 2, 2023
Standards for clinical trials for treating TBP du Cros, J Greig, J-W C Alffenaar, et al.
Nature Communications|October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugsSimon R Green, Susan H Davis, Sebastian Damerow, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
Allergy|December 10, 2020
Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy: The Markers of Nut Allergy StudyLucy Duan, Alper Celik, Jennifer A Hoang, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis TreatmentEric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
Aerobiologia|April 20, 2026
Five years of national airborne pollen monitoring in South Africa: biome-specific calendars to inform allergy diagnosis and preventionTakudzwa Matuvhunye, Dilys M Berman, Nanike Esterhuizen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 18, 2026
Age-Appropriate Low Dosing for FPIES Oral Food Challenges: Proposing a Standardized ApproachSara Anvari, Mary Grace Baker, Theresa Bingemann, et al.
Nature Communications|October 22, 2025
The role of cytochrome bc<sub>1</sub> inhibitors in future tuberculosis treatment regimensClara Aguilar-Pérez, Anne J Lenaerts, Cristina Villellas, et al.
The Lancet. Infectious Diseases|August 21, 2025
A clinical practice guideline for tuberculous meningitisJoseph Donovan, Fiona V Cresswell, Elizabeth W Tucker, et al.
Nature Medicine|July 6, 2021
The Tuberculosis Drug Accelerator at year 10: what have we learned?Bree B Aldridge, David Barros-Aguirre, Clifton E Barry, et al.
The Journal of Experimental Medicine|November 11, 2024
Human ITGAV variants are associated with immune dysregulation, brain abnormalities, and colitisSina Ghasempour, Neil Warner, Rei Guan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 2, 2023
Standards for clinical trials for treating TBP du Cros, J Greig, J-W C Alffenaar, et al.
Nature Communications|October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugsSimon R Green, Susan H Davis, Sebastian Damerow, et al.
Pageof 26